Protein Kinase D1 attenuates tumorigenesis in colon cancer by modulating β-catenin/T cell factor activity

Oncotarget

Volumn 5, Issue 16, 2014, Pages 6867-6884

  Sundram, Vasudha ^a   Ganju, Aditya ^b   Hughes, Joshua E ^a   Khan, Sheema ^b   Chauhan, Subhash C ^b   Jaggi, Meena ^b  

^a SANFORD RESEARCH   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Cell invasion; Cell motility; Colon Cancer; PKD1; T cell factor activity (TCF); Tumor suppressor; catenin

Indexed keywords

BETA CATENIN; PROTEIN KINASE; PROTEIN KINASE D1; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG; CTNNB1 PROTEIN, HUMAN; POLYCYSTIC KIDNEY DISEASE 1 PROTEIN; POLYCYSTIN; T CELL FACTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; CELL ADHESION; CELL AGGREGATION; CELL MOTILITY; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLONOGENESIS; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MODULATION; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; T LYMPHOCYTE; TUMOR XENOGRAFT; ANIMAL; BIOSYNTHESIS; CELL FRACTIONATION; COLON TUMOR; ENZYMOLOGY; GENETICS; HT 29 CELL LINE; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; BETA CATENIN; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DOWN-REGULATION; HETEROGRAFTS; HT29 CELLS; HUMANS; MALE; MICE; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; TCF TRANSCRIPTION FACTORS; TRPP CATION CHANNELS;

EID: 84907081115     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2277     Document Type: Article

References (49)

1. Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, Eheman C, Saraiya M, Bandi P, Saslow D, Cronin KA, Watson M, Schiffman M, Henley SJ, Schymura MJ and Anderson RN, et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013; 105(3):175-201.
2. Schneikert J and Behrens J. The canonical Wnt signalling pathway and its APC partner in colon cancer development. Gut. 2007; 56(3):417-425.
3. Korkaya H, Paulson A, Charafe-Jauffret E, Ginestier C, Brown M, Dutcher J, Clouthier SG and Wicha MS. Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling. PLoS biology. 2009; 7(6):e1000121.
4. Greenspan EJ, Madigan JP, Boardman LA and Rosenberg DW. Ibuprofen inhibits activation of nuclear {beta}-catenin in human colon adenomas and induces the phosphorylation of GSK-3{beta}. Cancer Prev Res (Phila). 2011; 4(1):161-171.
5. Moon RT, Kohn AD, Ferrari GVD and Kaykas A. WNT and [beta]-catenin signalling: diseases and therapies. Nat Rev Genet. 2004; 5(9):691-701.
6. MacDonald BT, Tamai K and He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009; 17(1):9-26.
7. Verheyen EM and Gottardi CJ. Regulation of Wnt/beta- catenin signaling by protein kinases. Developmental dynamics: an official publication of the American Association of Anatomists. 2010; 239(1):34-44.
8. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B and Clevers H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science. 1997; 275(5307):1784-1787.
9. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, Tjon-Pon-Fong M, Moerer P, van den Born M, Soete G, Pals S and Eilers M. The beta- catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell. 2002; 111(2):241-250.
10. Sundram V, Chauhan SC and Jaggi M. Emerging Roles of Protein Kinase D1 in Cancer. Mol Cancer Res. 2011; 9(8):985-996.
11. Jaggi M, Du C, Zhang W and Balaji KC. Protein kinase D1: a protein of emerging translational interest. Front Biosci. 2007; 12:3757-3767.
12. Rozengurt E, Rey O and Waldron RT. Protein kinase D signaling. The Journal of biological chemistry. 2005; 280(14):13205-13208.
13. Eiseler T, Doppler H, Yan IK, Goodison S and Storz P. Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion. Breast Cancer Res. 2009; 11(1):R13.
14. Eiseler T, Doppler H, Yan IK, Kitatani K, Mizuno K and Storz P. Protein kinase D1 regulates cofilin-mediated F-actin reorganization and cell motility through slingshot. Nat Cell Biol. 2009; 11(5):545-556.
15. Hassan S, Biswas MH, Zhang C, Du C and Balaji KC. Heat shock protein 27 mediates repression of androgen receptor function by protein kinase D1 in prostate cancer cells. Oncogene. 2009; 28(49):4386-4396.
16. Du C, Zhang C, Hassan S, Biswas MH and Balaji KC. Protein kinase D1 suppresses epithelial-to-mesenchymal transition through phosphorylation of snail. Cancer Res. 2010; 70(20):7810-7819.
17. Biswas MH, Du C, Zhang C, Straubhaar J, Languino LR and Balaji KC. Protein kinase D1 inhibits cell proliferation through matrix metalloproteinase-2 and matrix metalloproteinase- 9 secretion in prostate cancer. Cancer Res. 2010; 70(5):2095-2104.
18. Peterburs P, Heering J, Link G, Pfizenmaier K, Olayioye MA and Hausser A. Protein kinase D regulates cell migration by direct phosphorylation of the cofilin phosphatase slingshot 1 like. Cancer Res. 2009; 69(14):5634-5638.
19. Jaggi M, Chauhan SC, Du C and Balaji KC. Bryostatin 1 modulates beta-catenin subcellular localization and transcription activity through protein kinase D1 activation. Mol Cancer Ther. 2008; 7(9):2703-2712.
20. Jaggi M, Rao PS, Smith DJ, Hemstreet GP and Balaji KC. Protein kinase C mu is down-regulated in androgen-independent prostate cancer. Biochem Biophys Res Commun. 2003; 307(2):254-260.
21. Jaggi M, Rao PS, Smith DJ, Wheelock MJ, Johnson KR, Hemstreet GP and Balaji KC. E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancer. Cancer research. 2005; 65(2):483-492.
22. Borges S, Doppler H, Perez EA, Andorfer CA, Sun Z, Anastasiadis PZ, Thompson E, Geiger XJ and Storz P. Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis. Breast cancer research: BCR. 2013; 15(2):R66.
23. Du C, Jaggi M, Zhang C and Balaji KC. Protein kinase D1- mediated phosphorylation and subcellular localization of beta-catenin. Cancer Res. 2009; 69(3):1117-1124.
24. Mak P, Jaggi M, Syed V, Chauhan SC, Hassan S, Biswas H and Balaji KC. Protein kinase D1 (PKD1) influences androgen receptor (AR) function in prostate cancer cells. Biochem Biophys Res Commun. 2008; 373(4):618-623.
25. Kisfalvi K, Hurd C, Guha S and Rozengurt E. Induced overexpression of protein kinase D1 stimulates mitogenic signaling in human pancreatic carcinoma PANC-1 cells. J Cell Physiol. 2010; 223(2):309-316.
26. Syed V, Mak P, Du C and Balaji KC. Beta-catenin mediates alteration in cell proliferation, motility and invasion of prostate cancer cells by differential expression of E-cadherin and protein kinase D1. J Cell Biochem. 2008; 104(1):82-95.
27. Eiseler T, Hausser A, De Kimpe L, Van Lint J and Pfizenmaier K. Protein kinase D controls actin polymerization and cell motility through phosphorylation of cortactin. J Biol Chem. 2010; 285(24):18672-18683.
28. Eiseler T, Schmid MA, Topbas F, Pfizenmaier K and Hausser A. PKD is recruited to sites of actin remodelling at the leading edge and negatively regulates cell migration. FEBS Lett. 2007; 581(22):4279-4287.
29. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006; 127(3):469-480.
30. Du C, Jaggi M, Zhang C and Balaji KC. Protein Kinase D1- Mediated Phosphorylation and Subcellular Localization of {beta}-Catenin. Cancer Res. 2009; 69(3):1117-1124.
31. Sundram V, Chauhan SC, Ebeling M and Jaggi M. Curcumin attenuates beta-catenin signaling in prostate cancer cells through activation of protein kinase D1. PloS one. 2012; 7(4):e35368.
32. Bastea LI, Doppler H, Balogun B and Storz P. Protein kinase D1 maintains the epithelial phenotype by inducing a DNA-bound, inactive SNAI1 transcriptional repressor complex. PLoS One. 2012; 7(1):e30459.
33. Borges S, Doppler H, Perez EA, Andorfer CA, Sun Z, Anastasiadis PZ, Thompson EA, Geiger XJ and Storz P. Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis. Breast Cancer Res. 2013; 15(2):R66.
34. Doppler H, Bastea LI, Eiseler T and Storz P. Neuregulin mediates F-actin-driven cell migration through inhibition of protein kinase D1 via Rac1 protein. J Biol Chem. 2013; 288(1):455-465.
35. Storz P. Protein kinase D1: a novel regulator of actin-driven directed cell migration. Cell Cycle. 2009; 8(13):1975-1976.
36. Eisenberg-Lerner A and Kimchi A. PKD is a kinase of Vps34 that mediates ROS-induced autophagy downstream of DAPk. Cell Death Differ. 2012; 19(5):788-797.
37. Eisenberg-Lerner A and Kimchi A. DAP kinase regulates JNK signaling by binding and activating protein kinase D under oxidative stress. Cell Death Differ. 2007; 14(11):1908-1915.
38. Eisenberg-Lerner A and Kimchi A. PKD at the crossroads of necrosis and autophagy. Autophagy. 2012; 8:433-434.
39. Sullivan R and Graham C. Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev. 2007; 26(2):319-331.
40. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003; 3(10):721-732.
41. Qin L, Zeng H and Zhao D. Requirement of protein kinase D tyrosine phosphorylation for VEGF-A165- induced angiogenesis through its interaction and regulation of phospholipase Cgamma phosphorylation. J Biol Chem. 2006; 281(43):32550-32558.
42. Ha CH, Jhun BS, Kao HY and Jin ZG. VEGF stimulates HDAC7 phosphorylation and cytoplasmic accumulation modulating matrix metalloproteinase expression and angiogenesis. Arterioscler Thromb Vasc Biol. 2008; 28(10):1782-1788.
43. Ha CH, Wang W, Jhun BS, Wong C, Hausser A, Pfizenmaier K, McKinsey TA, Olson EN and Jin ZG. Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis. J Biol Chem. 2008; 283(21):14590-14599.
44. Wheelock MJ and Johnson KR. Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol. 2003; 19:207-235.
45. Johnson KR, Lewis JE, Li D, Wahl J, Soler AP, Knudsen KA and Wheelock MJ. P- and E-cadherin are in separate complexes in cells expressing both cadherins. Exp Cell Res. 1993; 207(2):252-260.
46. Gupta BK, Maher DM, Ebeling MC, Sundram V, Koch MD, Lynch DW, Bohlmeyer T, Watanabe A, Aburatani H, Puumala SE, Jaggi M and Chauhan SC. Increased expression and aberrant localization of mucin 13 in metastatic colon cancer. The journal of histochemistry and cytochemistry: official journal of the Histochemistry Society. 2012; 60(11):822-831.
47. Chauhan SC, Ebeling MC, Maher DM, Koch MD, Watanabe A, Aburatani H, Lio Y and Jaggi M. MUC13 mucin augments pancreatic tumorigenesis. Mol Cancer Ther. 2012; 11(1):24-33.
48. Yallapu MM, Maher DM, Sundram V, Bell MC, Jaggi M and Chauhan SC. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J Ovarian Res. 2010; 3:11.
49. Chauhan SC, Vannatta K, Ebeling MC, Vinayek N, Watanabe A, Pandey KK, Bell MC, Koch MD, Aburatani H, Lio Y and Jaggi M. Expression and functions of transmembrane mucin MUC13 in ovarian cancer. Cancer research. 2009; 69(3):765-774.